CD19 and B-cell chronic lymphocytic leukemia: In two patients with chronic lymphocytic leukemia, persistently active CD19 CAR-T cells achieved complete remission (CR) after infusion, with detectable CAR-T cells maintained for more than a decade while remission persisted.